-
COVID-19: post infection implications in different age groups, mechanism, diagnosis, effective prevention, treatment, and recommendations
Authors:
Muhammad Akmal Raheem,
Muhammad Ajwad Rahim,
Ijaz Gul,
Md. Reyad-ul-Ferdous,
Liyan Le,
Junguo Hui,
Shuiwei Xia,
Minjiang Chen,
Dongmei Yu,
Vijay Pandey,
Peiwu Qin,
Jiansong Ji
Abstract:
SARS-CoV-2, the highly contagious pathogen responsible for the COVID-19 pandemic, has persistent effects that begin four weeks after initial infection and last for an undetermined duration. These chronic effects are more harmful than acute ones. This review explores the long-term impact of the virus on various human organs, including the pulmonary, cardiovascular, neurological, reproductive, gastr…
▽ More
SARS-CoV-2, the highly contagious pathogen responsible for the COVID-19 pandemic, has persistent effects that begin four weeks after initial infection and last for an undetermined duration. These chronic effects are more harmful than acute ones. This review explores the long-term impact of the virus on various human organs, including the pulmonary, cardiovascular, neurological, reproductive, gastrointestinal, musculoskeletal, endocrine, and lymphoid systems, particularly in older adults. Regarding diagnosis, RT-PCR is the gold standard for detecting COVID-19, though it requires specialized equipment, skilled personnel, and considerable time to produce results. To address these limitations, artificial intelligence in imaging and microfluidics technologies offers promising alternatives for diagnosing COVID-19 efficiently. Pharmacological and non-pharmacological strategies are effective in mitigating the persistent impacts of COVID-19. These strategies enhance immunity in post-COVID-19 patients by reducing cytokine release syndrome, improving T cell response, and increasing the circulation of activated natural killer and CD8 T cells in blood and tissues. This, in turn, alleviates symptoms such as fever, nausea, fatigue, muscle weakness, and pain. Vaccines, including inactivated viral, live attenuated viral, protein subunit, viral vectored, mRNA, DNA, and nanoparticle vaccines, significantly reduce the adverse long-term effects of the virus. However, no vaccine has been reported to provide lifetime protection against COVID-19. Consequently, protective measures such as physical distancing, mask usage, and hand hygiene remain essential strategies. This review offers a comprehensive understanding of the persistent effects of COVID-19 on individuals of varying ages, along with insights into diagnosis, treatment, vaccination, and future preventative measures against the spread of SARS-CoV-2.
△ Less
Submitted 2 June, 2024;
originally announced June 2024.
-
Current and perspective sensing methods for monkeypox virus: a reemerging zoonosis in its infancy
Authors:
Ijaz Gul,
Changyue Liu,
Yuan Xi,
Zhicheng Du,
Shiyao Zhai,
Zhengyang Lei,
Chen Qun,
Muhammad Akmal Raheem,
Qian He,
Zhang Haihui,
Canyang Zhang,
Runming Wang,
Sanyang Han,
Du Ke,
Peiwu Qin
Abstract:
Objectives The review is dedicated to evaluate the current monkeypox virus (MPXV) detection methods, discuss their pros and cons, and provide recommended solutions to the problems.
Methods The literature for this review is identified through searches in PubMed, Web of Science, Google Scholar, ResearchGate, and Science Direct advanced search for articles published in English without any start dat…
▽ More
Objectives The review is dedicated to evaluate the current monkeypox virus (MPXV) detection methods, discuss their pros and cons, and provide recommended solutions to the problems.
Methods The literature for this review is identified through searches in PubMed, Web of Science, Google Scholar, ResearchGate, and Science Direct advanced search for articles published in English without any start date until June, 2022, by use of the terms "monkeypox virus" or "poxvirus" along with "diagnosis"; "PCR"; "real-time PCR"; "LAMP"; "RPA"; "immunoassay"; "reemergence"; "biothreat"; "endemic", and "multi-country outbreak" and also, by tracking citations of the relevant papers. The most relevant articles are included in the review.
Results Our literature review shows that PCR is the gold standard method for MPXV detection. In addition, loop-mediated isothermal amplification (LAMP) and recombinase polymerase amplification (RPA) have been reported as alternatives to PCR. Immunodiagnostics, whole particle detection, and image-based detection are the non-nucleic acid-based MPXV detection modalities.
Conclusions PCR is easy to leverage and adapt for a quick response to an outbreak, but the PCR-based MPXV detection approaches may not be suitable for marginalized settings. Limited progress has been made towards innovations in MPXV diagnostics, providing room for the development of novel detection techniques for this virus.
△ Less
Submitted 10 August, 2022;
originally announced August 2022.
-
RCMNet: A deep learning model assists CAR-T therapy for leukemia
Authors:
Ruitao Zhang,
Xueying Han,
Ijaz Gul,
Shiyao Zhai,
Ying Liu,
Yongbing Zhang,
Yuhan Dong,
Lan Ma,
Dongmei Yu,
** Zhou,
Peiwu Qin
Abstract:
Acute leukemia is a type of blood cancer with a high mortality rate. Current therapeutic methods include bone marrow transplantation, supportive therapy, and chemotherapy. Although a satisfactory remission of the disease can be achieved, the risk of recurrence is still high. Therefore, novel treatments are demanding. Chimeric antigen receptor-T (CAR-T) therapy has emerged as a promising approach t…
▽ More
Acute leukemia is a type of blood cancer with a high mortality rate. Current therapeutic methods include bone marrow transplantation, supportive therapy, and chemotherapy. Although a satisfactory remission of the disease can be achieved, the risk of recurrence is still high. Therefore, novel treatments are demanding. Chimeric antigen receptor-T (CAR-T) therapy has emerged as a promising approach to treat and cure acute leukemia. To harness the therapeutic potential of CAR-T cell therapy for blood diseases, reliable cell morphological identification is crucial. Nevertheless, the identification of CAR-T cells is a big challenge posed by their phenotypic similarity with other blood cells. To address this substantial clinical challenge, herein we first construct a CAR-T dataset with 500 original microscopy images after staining. Following that, we create a novel integrated model called RCMNet (ResNet18 with CBAM and MHSA) that combines the convolutional neural network (CNN) and Transformer. The model shows 99.63% top-1 accuracy on the public dataset. Compared with previous reports, our model obtains satisfactory results for image classification. Although testing on the CAR-T cells dataset, a decent performance is observed, which is attributed to the limited size of the dataset. Transfer learning is adapted for RCMNet and a maximum of 83.36% accuracy has been achieved, which is higher than other SOTA models. The study evaluates the effectiveness of RCMNet on a big public dataset and translates it to a clinical dataset for diagnostic applications.
△ Less
Submitted 6 May, 2022;
originally announced May 2022.
